[1] | Hepatology International|3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study[J]. Journal of Clinical Hepatology, 2024, 40(1): 128-128. doi: 10.12449/JCH2401.gwqkjpwzjj2 |
[2] | Hongliang WANG, Yuelin ZHANG, Kaibing WANG, Tanyang ZHOU, Guanhui ZHOU, Junhui SUN. Current status and advances in transjugular intrahepatic portosystemic shunt in treatment of refractory ascites due to portal hypertension[J]. Journal of Clinical Hepatology, 2023, 39(7): 1535-1540. doi: 10.3969/j.issn.1001-5256.2023.07.004 |
[3] | Hepatology|Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial[J]. Journal of Clinical Hepatology, 2022, 38(10): 2285-2285. doi: 10.3969/j.issn.1001-5256.2022.10.gwjpwzjj2 |
[4] | Hepatology|Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model[J]. Journal of Clinical Hepatology, 2022, 38(9): 1973-1973. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj1 |
[5] | Gonghai CHEN, Guangchuan WANG, Chunqing ZHANG. Current status of research on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2021, 37(5): 1201-1204. doi: 10.3969/j.issn.1001-5256.2021.05.047 |
[7] | Yao Xin, Zhou Hao, Tang ShanHong, Xie Min, Huang Shan, Qin JianPing. Stent dysfunction after transjugular intrahepatic portosystemic shunt: Causes and countermeasures[J]. Journal of Clinical Hepatology, 2019, 35(5): 1052-1056. doi: 10.3969/j.issn.1001-5256.2019.05.023 |
[8] | Wang Zhong, Liu FuQuan. Research advances in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(12): 2824-2827. doi: 10.3969/j.issn.1001-5256.2019.12.040 |
[9] | Jiang MingYuan, Huang Hua, Lu MingLiang, Lin FanYu, Zhang YingYuan. Application of anticoagulants after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(10): 2241-2244. doi: 10.3969/j.issn.1001-5256.2018.10.040 |
[12] | Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2017, 33(7): 1218-1228. doi: 10.3969/j.issn.1001-5256.2017.07.004 |
[13] | Xiao JiangQiang, ZhuGe YuZheng. Advances in transjugular intrahepatic portosystemic shunt and its application in treatment of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(2): 234-237. doi: 10.3969/j.issn.1001-5256.2016.02.006 |
[14] | Niu Meng, Sun Jun, Xu Ke, Zhong HongShan. Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China[J]. Journal of Clinical Hepatology, 2016, 32(2): 230-233. doi: 10.3969/j.issn.1001-5256.2016.02.005 |
[15] | Ren ShuYao, Chen Hui, Lu: Yong, Wang ZhengYu, Niu Jing, Yin ZhanXin, He ChuangYe, Guo WenGang, Han GuoHong. Hepatic myelopathy after transjugular intrahepatic portosystemic shunt:natural course,survival analysis,and treatment[J]. Journal of Clinical Hepatology, 2016, 32(6): 1112-1117. doi: 10.3969/j.issn.1001-5256.2016.06.018 |
[16] | Li Jing, Sun DongJie, Wang GuangChuan, Feng Hua, Shi YongJun, Zhang ChunQing. A comparative analysis of carvedilol and propranolol in hepatic venous pressure gradient reduction in patients with cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(1): 114-118. doi: 10.3969/j.issn.1001-5256.2016.01.021 |
[17] | Xu ZhengGuo, Zhao YongBing, Zheng YuanYu, Liu En, Yang ShiMing. Association between portal vein pressure drop gradient after transjugular intrahepatic portosystemic shunt and clinical prognosis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2016.12.019 |
[18] | Wang TingTing, Zhang Feng, ZhuGe YuZheng. Research progress in TIPS shunt dysfunction and recanalization[J]. Journal of Clinical Hepatology, 2015, 31(11): 1921-1923. doi: 10.3969/j.issn.1001-5256.2015.11.041 |
[19] | Hu WeiLin, Luo XiaoPing, Ling Ning, Shi XiaoFeng, Huang Ying, Yang YiXuan, Ceng WeiQun, He Hua, Zhang DaZhi. Treatment of hemoperitoneum following transjugular intrahepatic portosystemic shunt: a report of 4 cases and literature review[J]. Journal of Clinical Hepatology, 2015, 31(3): 443-446. doi: 10.3969/j.issn.1001-5256.2015.03.032 |